CARIS LIFE SCIENCES, INC. Finance Lease, Principal Payments
CARIS LIFE SCIENCES, INC. (CAI) reported Finance Lease, Principal Payments of $82.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for the quarter ending 2026-06-30 was $42.00K, a 90.91% increase year-over-year.
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for the quarter ending 2026-03-31 was $40.00K, a 81.82% increase year-over-year.
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for the quarter ending 2025-12-31 was $39.00K, a 85.71% increase year-over-year.
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for the quarter ending 2025-09-30 was $23.00K, a 11.54% decline year-over-year.
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for fiscal 2025 was $106.00K, a 32.48% decline from fiscal 2024.
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for fiscal 2024 was $157.00K, a 78.87% decline from fiscal 2023.
- CARIS LIFE SCIENCES, INC. finance lease, principal payments for fiscal 2023 was $743.00K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $82.00K 10-Q · filed 2026-08-05 | $121.00K derived: sum of 3 quarters · filed 2026-08-05 | $144.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $40.00K 10-Q · filed 2026-05-08 | $79.00K derived: sum of 2 quarters · filed 2026-05-08 | $102.00K derived: sum of 3 quarters · filed 2026-05-08 | $124.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $62.00K derived: sum of 2 quarters · filed 2026-03-03 | $84.00K derived: sum of 3 quarters · filed 2026-08-05 | $106.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $45.00K derived: sum of 2 quarters · filed 2026-08-05 | $67.00K 10-Q · filed 2025-11-05 | $88.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $44.00K 10-Q · filed 2026-08-05 | $65.00K derived: sum of 3 quarters · filed 2026-08-05 | $91.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $22.00K 10-Q · filed 2026-05-08 | $43.00K derived: sum of 2 quarters · filed 2026-05-08 | $69.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $47.00K derived: sum of 2 quarters · filed 2026-03-03 | $157.00K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $136.00K 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $110.00K 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $743.00K 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |